Experts at the Community Oncology Conference discuss innovative patient navigation programs, emphasizing technology's role ...

The Advanced Practitioner Society for Hematology and Oncology (APSHO) welcomes hematology/oncology advanced practitioners?nurse practitioners and physician assistants from Johns Hopkins Sidney Kimmel ...

Johnson & Johnson has generated evidence that the pace of oncology innovation is overwhelming physicians. | Johnson & Johnson ...

UnityPoint Health celebrated the expansion of the Cancer Center in Moline. The work renovated more than 10,000 square feet of ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

Nicole Hurley has an extra special memory to hold onto forever. During Friday's University of South Carolina's graduation, in ...

Elizabeth Fowler, PhD, JD , of the Johns Hopkins Bloomberg School of Public Health, former Deputy Administrator and Director ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

Pediatric patients with high-risk neuroblastoma had significantly lower 5-year survival rates in induction and/or ...

In collaboration with Prince Sultan Military Medical City Continuing Professional Development Department, and participation ...

Certified child life specialists are relatively unknown. Learn how they help pediatric patients navigate stressful hospital visits.